For the Inventor, By the Inventor

Enter assignee name

Allelix Biopharmaceuticals Inc.

USPTO Granted Patents = 64

CIPO Patents = 1

Forward Citations = 550

Loading Chart...

Loading Chart...

64 inventors (with patents filed for the assignee):

Sumanas Rakhit (17 out of 17 patents)

Rajender Kamboj (13 out of 33 patents)

Ashok Tehim (12 out of 71 patents)

4. Stephen L Nutt (10 out of 25 patents)

5. Jian-Min Fu (10 out of 10 patents)

6. Abdelmalik Slassi (7 out of 55 patents)

7. Louise G Edwards (5 out of 37 patents)

8. Candace E Elliott (5 out of 19 patents)

9. Michael A Wosnick (5 out of 6 patents)

10. Lee Shekter (5 out of 6 patents)

11. Martin Sumner-Smith (4 out of 14 patents)

12. Geoffrey L Hammond (4 out of 5 patents)

13. Donald G Munroe (3 out of 8 patents)

14. Tejal B Vyas (3 out of 7 patents)

15. Anne E Goodbody (3 out of 5 patents)

Core Competencies:

Glutamate Receptors

Dopamine Receptor Ligands

G-Protein Coupled Receptors

Muscarinic Receptor Ligands

Polynucleotide Encoding

Anti-Viral Compositions

5-HT Receptor Ligands

Peptide-Based Inhibitors

CNS Receptors

Bone-Stimulating Compounds

Piperidine-Indole Compounds

Alkyl-Substituted Compounds

64 patents: Sort by Forward Citations

1. 6136544 - Glutamate receptor (or EAA receptor) polynucleotides and their uses (2000-10-24),

2. 6133287 - Piperidine-indole compounds having 5-HT.sub.6 affinity (2000-10-17),

3. 6103715 - Dopamine receptor ligands (2000-08-15),

4. 6100291 - Pyrrolidine-indole compounds having 5-HT.sub.6 affinity (2000-08-08),

5. 6077949 - Cloned glucagon-like peptide 2 receptors (2000-06-20),

6. 6057126 - Mammalian EDG-5 receptor homologs (2000-05-02),

7. 6040175 - AMPA-binding human GluR2 receptors (2000-03-21),

8. 6020158 - Isolated polynucleotide for novel G-protein coupled receptor (2000-02-01),

9. 6018023 - Kainate-binding, human CNS receptors of the EAA3 family (2000-01-25),

10. 6013768 - Kainate-binding human CNS receptors of the EAA1 family (2000-01-11),

11. 5998462 - 5-alkyl indole compounds (1999-12-07),

12. 5998438 - 5-cyclo indole compounds (1999-12-07),

13. 5968478 - N- methyl piperazine compounds having dopamine receptor affinity (1999-10-19),

14. 5856510 - 5-alkenyl and 5-alkynyl indole compounds (1999-01-05),

15. 5849734 - Muscarinic receptor ligands (1998-12-15),

Allelix Biopharmaceuticals Inc. is a leading biotech company that specializes in the discovery and development of innovative drugs. With a focus on biopharmaceutical research, they strive to improve healthcare outcomes for patients worldwide. Through their cutting-edge technologies and dedicated team of scientists, Allelix is committed to bringing breakthrough therapies to market. Visit their website to learn more about their research, pipeline, and collaborations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

64 Patents

#22 in

#190 in Canada

#11,001 in the World

Allelix Biopharmaceuticals Inc.

Forward Citations = 550

64 inventors:

Sumanas Rakhit (17 out of 17 patents)

Rajender Kamboj (13 out of 33 patents)

Ashok Tehim (12 out of 71 patents)

4. Stephen L Nutt (10 out of 25 patents)

5. Jian-Min Fu (10 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…